Humbert M, Bourdin A, Taille C, Kamar D, et al. Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics. Eur Respir J 2022 May 26. pii: 13993003.03130-2021.
PMID: 35618272